These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8824496)

  • 1. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1996 Sep; 17(9):1785-90. PubMed ID: 8824496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the tamoxifen derivative metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen.
    Pongracz K; Pathak DN; Nakamura T; Burlingame AL; Bodell WJ
    Cancer Res; 1995 Jul; 55(14):3012-5. PubMed ID: 7606720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo.
    Beland FA; McDaniel LP; Marques MM
    Carcinogenesis; 1999 Mar; 20(3):471-7. PubMed ID: 10190564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxidase-mediated dealkylation of tamoxifen, detected by electrospray ionization-mass spectrometry, and activation to form DNA adducts.
    Gaikwad NW; Bodell WJ
    Free Radic Biol Med; 2012 Jan; 52(2):340-7. PubMed ID: 22064363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.
    Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC
    Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts.
    Shibutani S; Dasaradhi L; Terashima I; Banoglu E; Duffel MW
    Cancer Res; 1998 Feb; 58(4):647-53. PubMed ID: 9485016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen.
    Divi RL; Dragan YP; Pitot HC; Poirier MC
    Carcinogenesis; 2001 Oct; 22(10):1693-9. PubMed ID: 11577011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hepatic tamoxifen-DNA adducts in mice: alpha-(N(2)-deoxyguanosinyl)tamoxifen and alpha-(N(2)-deoxyguanosinyl)tamoxifen N-oxide.
    Umemoto A; Monden Y; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S; Komaki K
    Carcinogenesis; 2000 Sep; 21(9):1737-44. PubMed ID: 10964106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.
    Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC
    Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus.
    Li D; Dragan Y; Jordan VC; Wang M; Pitot HC
    Cancer Res; 1997 Apr; 57(8):1438-41. PubMed ID: 9108442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
    Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
    Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
    Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S
    Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers.
    Kim SY; Laxmi YR; Suzuki N; Ogura K; Watabe T; Duffel MW; Shibutani S
    Drug Metab Dispos; 2005 Nov; 33(11):1673-8. PubMed ID: 16099924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
    Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
    Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice.
    Umemoto A; Komaki K; Monden Y; Suwa M; Kanno Y; Kitagawa M; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
    Chem Res Toxicol; 2001 Aug; 14(8):1006-13. PubMed ID: 11511174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells.
    Osborne MR; Davis W; Hewer AJ; Hardcastle IR; Phillips DH
    Chem Res Toxicol; 1999 Feb; 12(2):151-8. PubMed ID: 10027792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
    Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.